Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.07 USD | -0.24% | -4.69% | +15.43% |
05-08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.43% | 3.11B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- RBC Raises Price Target on IDEAYA Biosciences to $36 From $32, Keeps Outperform Rating, Speculative Risk Qualifier